Solid Therapeutics ApS — Credit Rating and Financial Key Figures

CVR number: 43007068
Ole Maaløes Vej 3, 2200 København N

Income statement (kDKK)

2022
2023
2024
Fiscal period length121212
Net sales
Gross profit- 398.00-2 738.00-4 213.66
Employee benefit expenses- 364.00-1 455.00-3 033.40
EBIT- 762.00-4 193.00-7 247.06
Other financial income0.73
Other financial expenses- 113.00- 167.00-1 065.41
Pre-tax profit- 875.00-4 360.00-8 311.74
Income taxes78.00877.001 553.53
Net earnings- 797.00-3 483.00-6 758.21

Assets (kDKK)

2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables51.00107.00538.79
Current deferred tax assets78.00877.001 553.53
Short term receivables total129.00984.002 092.32
Cash and bank deposits3 447.009 830.008 911.51
Cash and cash equivalents3 447.009 830.008 911.51
Balance sheet total (assets)3 576.0010 814.0011 003.83

Equity and liabilities (kDKK)

2022
2023
2024
Share capital40.0040.0040.00
Retained earnings- 797.00-4 279.93
Profit of the financial year- 797.00-3 483.00-6 758.21
Shareholders equity total- 757.00-4 240.00-10 998.14
Non-current loans from credit institutions4 093.0014 256.0020 307.87
Non-current liabilities total4 093.0014 256.0020 307.87
Current trade creditors123.00610.00882.97
Other non-interest bearing current liabilities117.00188.00228.27
Accruals and deferred income582.86
Current liabilities total240.00798.001 694.10
Balance sheet total (liabilities)3 576.0010 814.0011 003.83
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.